| 201 |
Survival outcomes of CD34+CD38−LSCs and their expression of
CD123 in adult AML patients |
2018 |
| 202 |
Survival outcomes of CD34+CD38−LSCs and their expression of
CD123 in adult AML patients |
2018 |
| 203 |
Visfatin Serum Levels in Obese Type 2 Diabetic Patients: Relation to Proinflammatory Cytokines and Insulin Resistance |
2018 |
| 204 |
Visfatin Serum Levels in Obese Type 2 Diabetic Patients: Relation to Proinflammatory Cytokines and Insulin Resistance |
2018 |
| 205 |
Bedside inflammatory mediators in pulmonary tuberculosis |
2017 |
| 206 |
Carbapenem-hydrolyzing Oxacillinase Genes in Clinical Isolates of Acinetobacter baumannii |
2017 |
| 207 |
Co-occurrence of Plasmid-mediated Quinolone Resistance and Carbapenemases in Klebsiella pneumoniae Isolates in Assiut, Egypt |
2017 |
| 208 |
Co-occurrence of Plasmid-mediated Quinolone Resistance and Carbapenemases in Klebsiella pneumoniae Isolates in Assiut, Egypt |
2017 |
| 209 |
Co-occurrence of Plasmid-mediated Quinolone Resistance and Carbapenemases in Klebsiella pneumoniae Isolates in Assiut, Egypt |
2017 |
| 210 |
Divergent susceptibilities to AAV-SaCas9-gRNA vector-mediated genome-editing in a single-cell-derived cell population |
2017 |